CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 195 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823,598 | +20.7% | 27,957 | +33.7% | 0.00% | – |
| Q2 2023 | $682,198 | -9.2% | 20,914 | -2.0% | 0.00% | – |
| Q1 2023 | $751,078 | -22.9% | 21,344 | +0.3% | 0.00% | -100.0% |
| Q4 2022 | $974,683 | -15.0% | 21,272 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $1,147,000 | +21.5% | 23,671 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $944,000 | +29.3% | 24,036 | +21.2% | 0.00% | – |
| Q1 2022 | $730,000 | -13.0% | 19,834 | +7.7% | 0.00% | – |
| Q4 2021 | $839,000 | +49.0% | 18,415 | +16.8% | 0.00% | – |
| Q3 2021 | $563,000 | +39.0% | 15,765 | -23.0% | 0.00% | – |
| Q2 2021 | $405,000 | -7.3% | 20,477 | +8.9% | 0.00% | – |
| Q1 2021 | $437,000 | +76.9% | 18,797 | +58.0% | 0.00% | – |
| Q4 2020 | $247,000 | -16.3% | 11,897 | -12.8% | 0.00% | – |
| Q3 2020 | $295,000 | -1.7% | 13,639 | +7.0% | 0.00% | – |
| Q2 2020 | $300,000 | +26.6% | 12,745 | -36.6% | 0.00% | – |
| Q1 2020 | $237,000 | – | 20,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
| RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
| BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
| DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
| Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
| WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
| LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
| Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
| Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |